Machine learning has multiple applications in diverse fields, ranging from natural language processing to healthcare. Bioinformatics and biology-related disciplines have not been left behind in the revolution. Before machine learning emerged, these disciplines faced the problem of extracting valuable insights from large biological datasets. But as of today, ML techniques such as deep learning can learn the features of complex datasets and present them in a manner that is easy to understand.
Machine learning is widely used in drug discovery—according to a 2023 Statista study, 75% of innovative biotech companies reduce research cycles by up to 50%. In this article, we are going to take a closer look at machine learning in bioinformatics and biology. But before that, let’s begin by having a quick look at what machine learning in biology and bioinformatics really means.


Machine learning is a subset of artificial intelligence that gives systems the ability to learn from data and perform tasks without being explicitly programmed. While this technology has been around for years, it is a recent development to apply complex mathematical calculations to big data. Below are some widely-used machine learning applications that you might already be familiar with:
Of course, the list of examples is far longer, but that’s a different story.

Interested in machine learning? Read our article: Machine Learning. What it is and why it is essential to business?

There are three main branches of machine learning models. These include:
With the basics explained, let’s focus on bioinformatics.
Shortly put, bioinformatics is the application of computational and analysis techniques to capture and interpret biological data. It’s an interdisciplinary field between computer science, mathematics, statistics, biology, and genetics. Bioinformatics is mainly used to identify genes and nucleotides to better understand genetic diseases. It’s closely related to computational biology. Most people use the two terms interchangeably. But in the real sense, they are two distinct fields.
Let’s have a closer look at the two.
Computational biology and bioinformatics are interdisciplinary approaches to life sciences. They draw from empirical disciplines such as information science, computer science, physics, and mathematics.
Both fields have emerged from the rapid growth of biotechnology around the globe and are often used in research centers, laboratories, and colleges.
While the two disciplines may sound similar, they are distinct in the kinds of needs they address.
Below are some of the main differences between them for reference and clarification.
| Aspect | Bioinformatics | Computational Biology |
|---|---|---|
| Primary Focus | Managing, storing, analyzing, and interpreting biological data | Modeling biological systems to understand and predict processes |
| Main Objective | Build tools, algorithms, and databases for biological data analysis | Use computational methods to solve biological questions and generate insights |
| Type of Work | Data processing, sequence analysis, database and pipeline development | Mathematical modeling, simulations, and theoretical/computational analysis |
| Role in Research Workflow | Provides infrastructure, curated datasets, and analytical tools | Builds on processed data to test hypotheses and explain mechanisms |
| Typical Applications | Personalized medicine, microbial genomics, drug development, preventive medicine | Stochastic models, oncology research, genetic analysis, animal physiology |
One of the most transformative breakthroughs in computational biology has been the development of AlphaFold2 by DeepMind. This deep learning system predicts three-dimensional protein structures directly from amino acid sequences with unprecedented accuracy.
The release of predicted structures for millions of proteins has significantly accelerated:
drug discovery,
enzyme engineering,
functional annotation of previously uncharacterized proteins.
More recently, AlphaFold-Multimer and similar models have enabled prediction of protein complexes, further extending the scope of structural bioinformatics.
This marks a shift from data analysis to structure-level biological inference powered by machine learning.
Genomics is an essential domain of bioinformatics that focuses on studying genome mapping, evolution, and editing. A genome is a complete set of genetic material found in an organism. There are three main subsets of genomics;
Machine learning methods combined with natural language processing have allowed researchers to analyze large amounts of genomics-related biological data. This way, they can easily solve problems such as relation extraction and named entity recognition.
Currently, the industry has a wide range of products and services in the commercial sector, thanks to machine learning. According to research, the industry is projected to reach a smashing 54.4 billion USD by 2025. Some of the applications of the ML in genomics include:
Next-generation sequencing (NGS) technologies dramatically reduced both the cost and time required for whole-genome sequencing. While the Human Genome Project took over a decade due to technological and infrastructural limitations of the time, modern high-throughput sequencing platforms can sequence a human genome within days at a fraction of the original cost.
Machine learning enhances NGS workflows by improving:
Tools such as DeepVariant apply deep neural networks to improve variant detection accuracy beyond traditional statistical models.
Gene editing is the process of manipulating the genetic composition of an organism by inserting, deleting, or replacing a DNA sequence. It uses a technology called CRISPR, which is a faster and cheaper method of conducting the process.
However, researchers still need to do the legwork of selecting the right DNA sequence, which can be a long process susceptible to errors. Machine learning has come to the rescue by making it easier to identify the correct target audience, significantly reducing the cost and time required to perform gene editing.
Proteomics is the study of protein components, their interactions with each other, and their roles in an organism. Mass-spectrometry-enabled proteomics has made it possible to analyze thousands of human proteins.
However, computational and experimental challenges have restricted its progress, requiring informatics solutions such as machine learning to analyze and interpret massive biological data sets. Mass spectrometry is an analytical tool used to characterize biological samples and is used in omics studies due to its high-throughput activities.
Mass spectrometry does not measure proteins directly in their conventional form. Instead, it splits them up into smaller chunks of amino acid sequences of about 30 building blocks. It then compares them with the database and assigns the amino acids to specific proteins. The results are not entirely accurate because some proteins are not recognized correctly.
Machine learning methods can be applied to identify a wide range of proteins from a given sample. They can be used on:
These techniques have been helpful in the diagnosis of different types of diseases and have an obvious advantage over traditional methods such as enzyme-linked immunosorbent assays (ELISAs), protein arrays, affinity separation, 2D gel electrophoresis, among others.
Recent advancements in the use of Machine learning in proteomics include the development of a software called Prosit[4]. It was used successfully by a team of researchers in the Technical University of Munich (TUM) to quickly recognize protein patterns without errors.
Microarrays are laboratory tools used to detect multiple gene expressions at a go. With the increasing popularity of genetic studies in animals, plants, and microbes, this technology is helpful in studying genome organization, gene expression, and chromatin structures.
A microarray is made up of different probes (DNA, RNA, tissues, proteins, and peptides) that correspond to gene segments placed in a specific arrangement, mostly on a silicon microchip or glass slide. The theory behind this technology is that complementary sequences will bind to each other under the right conditions, while non-contemporary ones will not bind. The level of hybridization between contemporary probes is indicated by fluorescence.
The level of complexity in microarray data sets is increasing at a rapid pace. Large-scale experiments require thousands of probes to be monitored simultaneously. Machine learning has made it easier to spot significant interactions involved in complex experiments. It has been used widely in microarray analysis, with gene classification and clustering being some of the most cited examples.
Neural Designer, for example, has made it possible for researchers to discover intricate relationships and identify complex patterns in microarray data by the use of machine learning methods. Public databases such as Array Express record all the information about a microarray experiment, making it readily available for reuse by the research community.
Some of the applications of machine learning methods on microarrays include:
While microarrays played a foundational role in gene expression analysis, modern biology increasingly relies on single-cell sequencing technologies (scRNA-seq, scATAC-seq) and spatial transcriptomics.
These technologies generate extremely high-dimensional data requiring advanced machine learning techniques for:
dimensionality reduction,
batch effect correction,
cell-type classification,
trajectory inference,
multi-modal data integration.
Deep generative models and variational autoencoders are frequently used to analyze and integrate single-cell datasets.
Recent advances in large language models (LLMs) have significantly improved biomedical text mining. Transformer-based architectures can now extract complex relationships between genes, proteins, diseases, and drugs from millions of scientific publications.
Text mining is also referred to as text analytics. It’s a machine learning-powered technology that uses natural language processing to examine large volumes of documents and discover new information that helps answer research questions.
The increase in biological publications has made it difficult for researchers to search through different sources and compile relevant information on a given topic. Machine learning can work through different types of human-generated reports in databases to process and analyze data, reducing labor costs and speeding up the research process without compromising quality.
ML text analysis can be used in bioinformatics for:

Read our Case Study about Enhancing Data Infrastructure to Improve Business Analytics

Systems biology is the computational and mathematical analysis of the interactions and behavior of biological components such as molecules, cells, organs, and organisms. Computational modeling is a valuable tool used in this discipline. It uses mathematical modeling to capture the interactions between biological components and simulate the whole system’s behavior. However, it’s hard to build a steady mathematical model due to the complexity and lack of proper understanding of the underlying mechanisms.
But with the use of data-driven machine learning methods, it has become easier to model complex interactions in domains such as signal transduction networks, genetic networks, and metabolic pathways.
Machine learning is helpful in biological systems with sufficient biological data but not enough biological knowledge to develop theory-based models. A great example is the identification of the relationship between the phenotype and genotype of S. cerevisiae.
Even though there are many strains of characterized phonomes and genomes, there is still the unavailability of theory-based models that illustrate how the difference in genotypes dictates the strain phenotypes. Machine learning is used in this situation to establish the relationship between phenotypes and genotypes by training a supervised model with genomes as input and phenomes as output. The interpretation of the resulting model gives hints on the critical genetic composition of the organism. It helps in the identification of the most crucial factors that contribute to the model’s predictive power.
One of the most used machine learning techniques in systems biology is the probabilistic graphical model. It figures out the structure between different variables and is used to model genetic networks. Another common technique is genetic algorithms. It’s based on the natural process of evolution and has also been used to model genetic networks and regulatory structures.
Machine learning is also used to solve systems biology problems, such as the identification of transcription binding sites by the use of a technique called Markov chain optimization. A Markov Chain is a stochastic model that describes a sequence of possible events by relying on biological data obtained from previous events.
In recent years, graph neural networks (GNNs) have become a standard approach for modeling molecular structures. Additionally, generative models such as diffusion models and reinforcement learning-based systems are increasingly used to design novel drug candidates with optimized chemical and pharmacological properties.
These approaches enable de novo molecule design rather than simple screening of existing compound libraries.
Machine learning and artificial intelligence are being used extensively in healthcare facilities to improve patient care and enhance the quality of life. Soon, hospitals might be able to use machine learning-based technology to obtain real-time data from multiple healthcare systems in different countries, increasing the efficiency of treatment. Some of the main applications of ML in healthcare include:
Machine learning is widely used in the early stages of drug discovery processes. Some of the research and development technologies used include precision medicine and next-generation sequencing. They have proven to be helpful in finding alternative options for multifactorial disease therapy.
Deep learning and machine learning have been used on a breakthrough technology known as computer vision. The technology has found acceptance in a wide range of applications. An example is Microsoft’s InnerEye project that builds innovative tools for quantitative analysis of 3D medical images.
Predictive analytics can be used on patient data to facilitate personalized treatment. Currently, doctors are limited to a specific set of diagnoses or are forced to estimate the risk of a disease on a patient based on their health history and limited genetic information. However, this could change soon because machine learning is making great strides in medicine by leveraging patient data to help generate a wide range of treatment options.
Machine learning uses pattern recognition to help diagnose, treat, and predict complications in various neurological diseases. Over the past few years, Acute Ischemic Stroke (AIS) treatment has experienced significant advancement. Machine learning algorithms are now being used to predict motor deficits in stroke patients. The most commonly used methods are Support Vector Machines (SVM), and 3D Conventional Neural Network (CNN).
Inspired by large language models in NLP, foundation models are now emerging in biology. These models are trained on massive biological datasets such as:
genomic sequences,
protein sequences,
multi-omics profiles.
Examples include:
ESM (Evolutionary Scale Modeling),
ProtBERT,
genomic transformer models such as Enformer.
These models learn general biological representations that can be fine-tuned for specific downstream tasks such as mutation effect prediction, protein stability modeling, or regulatory element identification.
Foundation models represent a paradigm shift from task-specific modeling to transferable biological representations.
This is a deep-learning tool that is used in genome data mining. It can predict common genetic variations more accurately as compared to previous classical methods. DeepVariant is one of the first biological tools that leverage machine learning and Google’s computing to provide a scalable, cloud-based solution that satisfies the needs of the most complex genomics data sets.
Atomwise is a biotech company based in San Francisco that developed the first deep learning-based algorithm that helps convert molecules to 3D pixels. This conversion helps in the study of the 3D structure of proteins and other molecules with atomic precision.
Also, it basically predicts molecules that can possibly interact with a specific protein. The algorithms are mainly used in drug discovery.
In the past, biological imaging software could only measure a single parameter of a group of images. However, that has changed, thanks to machine-learning methods. Scientists can now prepare and image a countless number of samples per day by using the CellProfiler software.
Moreover, the software can quantitatively measure individual features such as the number of fluorescent cells in a microscopy field. It can also point out thousands of cell features by the use of deep learning techniques.
Machine learning through deep learning algorithms extracts meaningful information from huge datasets such as genomes or a group of images and builds a model based on the extracted features. The model is then used to perform analysis on other biological datasets.
Despite its transformative potential, machine learning in biology faces several important challenges:
Acknowledging these limitations is essential for responsible and sustainable use of machine learning in life sciences.
One of the most pressing issues in bioinformatics and biology as a whole is the processing of huge datasets generated by newly developed technologies into meaningful information. However, as we step into the era of artificial intelligence and big data, machine learning in bioinformatics is taking a central role in carrying out this transformation.
This article has highlighted some of the essential concepts of machine learning and its recent applications in biology and bioinformatics. We have seen that ML can be used to devise complex algorithms and models that help in the prediction of trends across different biological disciplines. Ultimately, for these models to succeed, they need quality data in terms of statistical power and sample sizes.
Machine learning is not replacing experimental biology but augmenting it. The most impactful applications arise when computational predictions are combined with biological validation.
The future of life sciences lies in hybrid, data-driven and mechanistic approaches where machine learning models support hypothesis generation, accelerate discovery, and enable personalized interventions — while remaining grounded in rigorous validation and ethical responsibility.

Check out our machine learning services to find out more

This article is an updated version of the publication from September 21, 2021. It was updated on February 23, 2026, to incorporate new technologies and tools, industry breakthroughs, and challenges in machine learning usage.
Biological data is often high-dimensional, noisy, and nonlinear. Traditional statistical models usually rely on predefined assumptions, while machine learning can automatically detect complex, nonlinear patterns without explicit programming. This makes ML especially effective for multi-omics integration, protein structure prediction, and large-scale genomic analysis where relationships are too intricate for classical approaches.
Beyond screening existing compounds, modern ML models can design entirely new molecules with optimized chemical and pharmacological properties. Techniques like generative models and reinforcement learning enable de novo drug design, reducing development timelines and focusing experimental efforts on the most promising candidates.
In healthcare and biology, predictive accuracy alone is insufficient. Clinicians and researchers need to understand why a model makes a prediction to ensure safety, regulatory compliance, and biological plausibility. Interpretable models can reveal potential biomarkers, causal pathways, or therapeutic targets, increasing trust and facilitating clinical adoption.
Foundation models trained on massive biological datasets can learn general-purpose biological representations. Instead of building separate models for each task, researchers can fine-tune these pretrained systems for specific problems, such as mutation impact prediction or regulatory element identification. This reduces development time and improves performance in data-scarce scenarios.
Overreliance on ML can lead to misleading conclusions if models are trained on biased, incomplete, or non-representative data. Additionally, without experimental validation, computational predictions may lack biological relevance. Sustainable progress requires integrating machine learning with rigorous experimental design, domain expertise, and ethical oversight.
Category:
Discover how AI turns CAD files, ERP data, and planning exports into structured knowledge graphs-ready for queries in engineering and digital twin operations.